Home › Cardiovascular Disease › Ohio › Akron
Cardiovascular Disease clinical trials in Akron, OH
3 studies for Cardiovascular Disease are looking for participants at sites in and around Akron (within about 30 miles). Open a study to see who can join and how to contact the study team.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Aultman Hospital, Canton · 21 mi away
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Akron Hospital Summa Health System, Akron
- Aultman Hospital, Canton · 21 mi away
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Aultman Cardiology Clinical Trials, Canton · 21 mi away
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN19 studies
Other studies in Akron
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer16 studies
- Cancer (all types)14 studies
- Breast Cancer13 studies
- Prostate Cancer9 studies
- Metastatic Cancer8 studies
- Colorectal Cancer8 studies
- Melanoma8 studies
- Acute Myeloid Leukemia8 studies
- Small Cell Lung Cancer8 studies
- Endometrial Cancer7 studies
- Steatotic Liver Disease7 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.